Hematology TimesDiabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology NewsPET-driven chemo strategy helps reduce toxicity in Hodgkin lymphomaJuly 6, 2018Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesInterim PET scans identify HL patients with better outcomesJune 16, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology NewsPhysical inactivity linked to lymphoma riskMay 18, 2018Indolent LymphomaHodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesUmbralisib has ‘distinct’ safety profileMay 16, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology Times‘Long-term benefits’ with nivolumab in cHLMay 9, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology NewsNovel targeted cancer drugs cause fewer arrhythmiasMay 8, 2018CMLHodgkin LymphomaPatient & Survivor CareBreast CancerLymphoma & Plasma Cell Disorders
Hematology TimesCHMP recommends approval for generic carmustineApril 28, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA places tazemetostat trials on partial holdApril 25, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesArt education benefits blood cancer patientsApril 23, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingTransplantationAML
Hematology TimesFDA approves BV plus chemo for untreated cHLMarch 21, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Hematology NewsFDA approves new option in Hodgkin lymphoma treatmentMarch 20, 2018Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesLymphoma, breast cancer survivors have greater risk of CHFMarch 13, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA approves label update for nivolumabMarch 8, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
Hematology TimesStudy confirms higher risk of infection with CB transplantMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
